Discover 3,069 paid clinical trials in Brockton, Massachusetts. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,069
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
for
Acute Myeloid Leukemia,
Location: Boston MA, Baltimore MD, Chapel Hill NC, Columbus OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT05886049
Phase1, Recruiting
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
for
Multiple Myeloma
Location: Boston MA, Canton OH, Wilson NC, Chapel Hill NC,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT05714839
Phase1, Phase2, Recruiting
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
for
Stroke
Location: Boston MA, Baltimore MD, Durham NC, Cincinnati OH,
Sponsor: State University of New York at Buffalo
Sex: All
Age: 18+
Code: NCT00682695
Recruiting
LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC
for
EGFRI Induced Acneiform Lesions
Location: Boston MA, New York NY, Neptune NJ, Philadelphia PA,
Sponsor: Lutris Pharma Ltd.
Sex: All
Age: 18+
Code: NCT04759664
Phase2, Recruiting
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
for
Myeloproliferative Neoplasms
Location: Boston MA, New York NY, Baltimore MD, Cleveland OH,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT06034002
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age
for
Cystic Fibrosis (CF)
Location: Boston MA, Buffalo NY, Richmond VA, Chapel Hill NC,
Sponsor: State University of New York at Buffalo
Sex: All
Age: 1 - 11
Code: NCT07048574
Recruiting
A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
for
Cancer
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute
Sex: All
Age: 18+
Code: NCT03310879
Phase2, Recruiting
Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults
Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma
for
Merkel Cell Carcinoma
Location: Boston MA, New York NY, Fairfax VA, Toronto,
Sponsor: Kartos Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT03787602
Phase1, Phase2, Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
for
Ulcerative Colitis, Obesity or Overweight
Location: Providence RI, New Bedford MA, Lebanon NH, Yonkers NY,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70
Code: NCT06937086
Phase3, Recruiting
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
for
Crohn's Disease, Obesity or Overweight
Location: Providence RI, New Bedford MA, Lebanon NH, Yonkers NY,
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
for
Systemic Lupus Erythematosus,
Location: Boston MA, Great Neck NY, New York NY, Rochester NY,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT06570798
Phase2, Recruiting
Featured
A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
for
Advanced High-Grade Epithelial Ovarian Cancer,
Location: Worcester MA, Pittsburgh PA, Detroit MI, Edgewood KY,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06682988
Phase2, Recruiting
Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
for
Castration Resistant Metastatic Prostate Cancer
Location: Boston MA, Baltimore MD, Minneapolis MN, Omaha NE,
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sex: Male
Age: 18 - 70+
Code: NCT04363164
Phase2, Recruiting
Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study